Pharma and Health Care Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Pharma and Health Care market size was valued at USD 1281950 million in 2022 and is forecast to a readjusted size of USD 1667520 million by 2029 with a CAGR of 3.8% during review period.

The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.

Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician. In this report, we mainly study the pharma and healthcare product.

North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 25%. Market competition is intense. The key players are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., etc. The top five vendors held 20% of the market share.

This report is a detailed and comprehensive analysis for global Pharma and Health Care market. Both quantitative and qualitative analyses are presented by company, by region & country, by Format and by Prescription. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Pharma and Health Care market size and forecasts, in consumption value ($ Million), 2018-2029
Global Pharma and Health Care market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Pharma and Health Care market size and forecasts, by Format and by Prescription, in consumption value ($ Million), 2018-2029
Global Pharma and Health Care market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharma and Health Care
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Pharma and Health Care market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Johnson & Johnson
   Novartis
   Roche
   AbbVie
   Merck & Co.
   Bristol Myers Squibb
   GlaxoSmithKline
   Pfizer
   Sanofi
   Takeda
   AstraZeneca
   Bayer
   Eli Lilly & Co.
   Gilead Sciences
   Amgen
   Novo Nordisk
   Teva
   Boehringer Ingelheim
   Biogen
   Astellas

   Bottle
   Blister
   Others

   OTC Drugs
   Prescription Drugs

   North America (United States, Canada, and Mexico)
   Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
   South America (Brazil, Argentina and Rest of South America)
   Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

What are the strengths of the Pharma and Healthcare Market in 2025?

The strengths of the Pharma and Healthcare Market in 2025 lie in the advancements in biotechnology, personalized medicine, and digital health innovations. These innovations offer improved patient outcomes and faster drug development processes. Moreover, increasing global healthcare needs and demand for better healthcare services, particularly in emerging markets, continue to fuel market growth.

What are the weaknesses of the Pharma and Healthcare Market in 2025?

One weakness is the rising cost of healthcare and drugs, which could limit access to essential treatments for lower-income populations. Regulatory hurdles and lengthy approval processes may also slow down the availability of new treatments. Additionally, there is a significant reliance on a few key players in the pharmaceutical sector, which could pose risks of monopolies or market inefficiencies.

What opportunities exist in the Pharma and Healthcare Market in 2025?

The market has opportunities for growth in areas such as AI-driven drug discovery, telemedicine, and health tech start-ups targeting specific patient needs. Expanding access to healthcare in underserved regions, coupled with personalized treatment options, offers significant market potential. Additionally, the aging global population presents an opportunity for increased demand for healthcare services and products.

What threats face the Pharma and Healthcare Market in 2025?

Threats include the potential for stringent regulatory changes and political instability, which could disrupt market growth. There is also the risk of data privacy concerns as digital health solutions become more prevalent. Furthermore, economic recessions or pandemics could lead to reduced healthcare spending, affecting the profitability of healthcare companies.

What are the political factors influencing the Pharma and Healthcare Market in 2025?

Political factors such as healthcare policies, government spending, and regulation play a crucial role in shaping the pharma and healthcare market. Policies around drug pricing, patents, and healthcare access directly affect market dynamics. Governments' investment in healthcare infrastructure and global trade agreements can also open up opportunities or pose challenges for international pharmaceutical companies.

What are the economic factors impacting the Pharma and Healthcare Market in 2025?

Economic factors such as economic recessions, inflation rates, and healthcare budgets can significantly influence market performance. Economic downturns may lead to reduced consumer spending on healthcare, affecting the affordability of treatments. However, growing wealth in emerging economies presents opportunities for healthcare providers and pharmaceutical companies to expand their reach.

What are the social factors affecting the Pharma and Healthcare Market in 2025?

Social factors like the aging population, changing patient demographics, and rising awareness of health and wellness trends influence market growth. The increasing demand for personalized medicine and chronic disease management services reflects societal shifts toward healthier lifestyles and longevity. There is also a growing focus on mental health, which could drive the market for related therapies.

What are the technological factors shaping the Pharma and Healthcare Market in 2025?

Technological advancements such as AI in drug discovery, telemedicine, and wearable health devices are transforming the healthcare sector. These innovations allow for better diagnostics, patient monitoring, and personalized treatment options. Technologies like blockchain also have the potential to improve data security and transparency within the healthcare ecosystem.

What are the environmental factors affecting the Pharma and Healthcare Market in 2025?

Environmental factors like sustainability and climate change are becoming more significant in the healthcare market. Pharmaceutical companies are under increasing pressure to adopt environmentally friendly practices, from production processes to packaging. Additionally, environmental health concerns, such as air and water pollution, may drive demand for healthcare services related to respiratory diseases and other environmental health issues.

What are the legal factors influencing the Pharma and Healthcare Market in 2025?

Legal factors such as intellectual property laws, drug approval processes, and healthcare regulations significantly impact the market. The evolving landscape of healthcare regulations, including privacy laws like GDPR and the FDA's stance on drug approvals, directly affects market operations. Laws surrounding drug pricing and patent protections are crucial for the financial viability of pharmaceutical companies.

Who are the suppliers in the Pharma and Healthcare Market in 2025?

Suppliers include pharmaceutical manufacturers, raw material providers, medical device producers, and technology companies providing digital health solutions. Research institutions and biotech firms also play a key role in supplying new drugs, treatments, and innovations that drive the market forward.

What are the inputs in the Pharma and Healthcare Market in 2025?

Inputs consist of raw materials for drug manufacturing, research data, regulatory guidelines, funding for healthcare infrastructure, and healthcare professionals. Additionally, technology investments in AI, data analytics, and telemedicine platforms are critical inputs for delivering healthcare services and advancing pharmaceutical development.

What are the processes in the Pharma and Healthcare Market in 2025?

Processes involve drug discovery, clinical trials, regulatory approval, manufacturing, and distribution. In healthcare, the processes include patient care delivery, diagnostics, treatment planning, and the use of technology for personalized medicine. These processes are all interconnected and aim to improve patient outcomes while maintaining operational efficiency.

What are the outputs in the Pharma and Healthcare Market in 2025?

Outputs include new pharmaceutical products, medical treatments, healthcare services, and innovative health technologies. The outcomes of these outputs are improved patient health, better disease management, and enhanced access to care. Additionally, more affordable and effective treatments will emerge from market-driven innovations.

Who are the customers in the Pharma and Healthcare Market in 2025?

Customers include patients seeking medical treatments, healthcare providers such as hospitals and clinics, insurance companies, and governments. Pharmaceutical companies also cater to healthcare professionals, researchers, and institutions by providing medicines and health solutions. The increasing demand from emerging markets for better healthcare access also defines a growing customer base.

What is the threat of new entrants in the Pharma and Healthcare Market in 2025?

The threat of new entrants is moderate in the pharma and healthcare market due to high barriers to entry, such as expensive research and development, regulatory hurdles, and the need for large capital investment. Established companies with patents, brand recognition, and distribution networks have a strong competitive advantage, making it difficult for new players to enter the market.

What is the bargaining power of suppliers in the Pharma and Healthcare Market in 2025?

The bargaining power of suppliers is moderate to high, especially for companies that provide essential raw materials, specialized technologies, or proprietary pharmaceutical ingredients. With increasing demand for innovative therapies and technologies, suppliers in the biotech, raw material, and technology sectors have significant influence over pricing and terms.

What is the bargaining power of buyers in the Pharma and Healthcare Market in 2025?

The bargaining power of buyers is increasing as healthcare consumers become more informed and demand personalized care. However, in many cases, patients have limited choices when it comes to treatment options due to the specialized nature of some medicines and therapies. Insurers and healthcare providers also exert bargaining power, influencing drug pricing and reimbursement decisions.

What is the threat of substitute products or services in the Pharma and Healthcare Market in 2025?

The threat of substitutes is moderate, as alternative therapies, such as herbal medicines, generic drugs, and telemedicine solutions, are gaining traction. However, many patients still rely on prescription drugs and traditional medical treatments, which are difficult to replace in certain conditions. Advances in personalized medicine may reduce the risk of substitutes by offering more targeted and effective treatments.

What is the intensity of competitive rivalry in the Pharma and Healthcare Market in 2025?

The intensity of competitive rivalry is high due to the presence of numerous global and regional players, constant innovation, and pricing pressures. Companies must continuously invest in R&D, marketing, and technology to stay ahead. Additionally, large pharmaceutical companies compete with emerging biotech firms and healthcare technology providers, increasing the competitive dynamics within the market.

What are the key upstream factors in the Pharma and Healthcare Market in 2025?

Key upstream factors include the availability of raw materials, the innovation in biotechnology, and advancements in research and development. The regulatory environment and patent laws also influence upstream activities, determining the time and costs associated with drug development and approval.

What role do suppliers play in the Pharma and Healthcare Market in 2025?

Suppliers play a critical role by providing the necessary raw materials, technologies, and expertise required for drug manufacturing and healthcare services. This includes active pharmaceutical ingredients (APIs), medical devices, lab equipment, and digital health solutions. Their ability to meet demand for high-quality inputs will directly impact the success of pharmaceutical companies and healthcare providers.

How does the regulatory environment impact the upstream activities in Pharma and Healthcare in 2025?

The regulatory environment is a major driver of upstream activities, as it dictates the approval processes for new drugs, medical devices, and healthcare technologies. Stringent regulations around safety, efficacy, and quality control can increase the time and cost of bringing products to market. This also impacts the supply chain, especially in terms of compliance and the ability to access global markets.

How do technological advancements influence upstream activities in the Pharma and Healthcare Market in 2025?

Technological advancements are increasingly shaping upstream activities by enabling more efficient drug discovery, production, and testing processes. Innovations such as AI in drug design, 3D printing in medical devices, and automation in manufacturing are reducing costs and speeding up the development cycle, ultimately contributing to more effective treatments and better healthcare solutions.

How does the global supply chain affect the Pharma and Healthcare Market in 2025?

Global supply chain dynamics significantly affect the availability of critical materials and the efficiency of distribution channels. Disruptions due to geopolitical issues, trade policies, or pandemics can delay the delivery of raw materials, such as active pharmaceutical ingredients, and affect the production and distribution of medicines and healthcare products. Therefore, securing resilient and diversified supply chains will be crucial for maintaining market stability.

What are the key midstream activities in the Pharma and Healthcare Market in 2025?

Key midstream activities involve the processing, formulation, and packaging of pharmaceutical products, as well as the development of healthcare services such as patient diagnostics, treatment plans, and clinical care delivery. These activities bridge the gap between raw material supply and the final delivery of healthcare solutions to end users.

How do manufacturing processes impact the Pharma and Healthcare Market in 2025?

Manufacturing processes are critical in ensuring the scalability, quality, and cost-effectiveness of pharmaceutical products and medical devices. Innovations in automated production, quality control, and adherence to regulatory standards will play a major role in driving efficiency and reducing costs in the pharma sector, directly impacting overall market competitiveness.

How does distribution impact midstream activities in Pharma and Healthcare in 2025?

Distribution plays a crucial role in ensuring that pharmaceutical products and healthcare services reach the end user efficiently. A robust distribution network is essential for maintaining the flow of products from manufacturers to hospitals, clinics, pharmacies, and ultimately to patients. Advances in logistics technology and supply chain management will become more important as global demand for healthcare products increases.

What role do healthcare professionals play in midstream activities in the Pharma and Healthcare Market in 2025?

Healthcare professionals, including doctors, nurses, pharmacists, and specialists, are pivotal in midstream activities as they facilitate the application of pharmaceutical products and healthcare services to patients. Their expertise is critical in ensuring the correct use of treatments, patient management, and the delivery of personalized care, all of which directly influence patient outcomes and the effectiveness of treatments.

How does market demand influence midstream activities in the Pharma and Healthcare Market in 2025?

Market demand drives midstream activities by influencing production schedules, resource allocation, and the development of new healthcare solutions. An increasing demand for personalized medicine, chronic disease management, and advanced medical technologies will push manufacturers and healthcare providers to innovate, scale, and improve the efficiency of midstream processes to meet these needs.

What are the key downstream activities in the Pharma and Healthcare Market in 2025?

Key downstream activities include the final delivery of pharmaceutical products and healthcare services to consumers, such as patients receiving treatments, diagnostic services, and medical consultations. These activities also encompass post-treatment care, patient monitoring, and the continued distribution of healthcare products through pharmacies and retail networks.

How does customer access impact downstream activities in Pharma and Healthcare in 2025?

Customer access plays a significant role in downstream activities by influencing how easily patients and healthcare providers can access medications, treatments, and healthcare services. The growth of telemedicine and online pharmacy services is increasing access to healthcare, particularly in underserved regions, while also improving convenience and affordability for patients.

What role do healthcare providers play in downstream activities in the Pharma and Healthcare Market in 2025?

Healthcare providers, including hospitals, clinics, and pharmacies, are critical in downstream activities as they are the direct link between pharmaceutical companies and patients. They ensure that patients receive appropriate treatments, monitor outcomes, and provide the necessary care for recovery and long-term health management. Their role in educating patients on treatment options is also vital to improving adherence to therapies.

How does patient experience affect downstream activities in Pharma and Healthcare in 2025?

Patient experience is crucial in driving the effectiveness and success of downstream activities. Positive experiences with treatments, healthcare providers, and services increase patient satisfaction, improve adherence to prescribed therapies, and contribute to better health outcomes. Personalization of care and more accessible healthcare services will become key factors in enhancing patient experiences and, consequently, market success.

What impact does digital health technology have on downstream activities in the Pharma and Healthcare Market in 2025?

Digital health technologies, such as mobile health apps, telemedicine platforms, and wearable health devices, significantly impact downstream activities by enabling continuous monitoring, real-time data collection, and more personalized patient care. These technologies empower patients to manage their health more effectively and allow healthcare providers to track progress, adjust treatments, and improve overall care delivery.

Chapter 1, to describe Pharma and Health Care product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharma and Health Care, with revenue, gross margin and global market share of Pharma and Health Care from 2018 to 2023.
Chapter 3, the Pharma and Health Care competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Format and application, with consumption value and growth rate by Format, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pharma and Health Care market forecast, by regions, format and prescription, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharma and Health Care.
Chapter 13, to describe Pharma and Health Care research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Pharma and Health Care
   1.2 Market Estimation Caveats and Base Year
   1.3 Classification of Pharma and Health Care by Format
       1.3.1 Overview: Global Pharma and Health Care Market Size by Format: 2018 Versus 2022 Versus 2029
       1.3.2 Global Pharma and Health Care Consumption Value Market Share by Format in 2022
       1.3.3 Bottle
       1.3.4 Blister
       1.3.5 Others
   1.4 Global Pharma and Health Care Market by Prescription
       1.4.1 Overview: Global Pharma and Health Care Market Size by Prescription: 2018 Versus 2022 Versus 2029
       1.4.2 OTC Drugs
       1.4.3 Prescription Drugs
   1.5 Global Pharma and Health Care Market Size & Forecast
   1.6 Global Pharma and Health Care Market Size and Forecast by Region
       1.6.1 Global Pharma and Health Care Market Size by Region: 2018 VS 2022 VS 2029
       1.6.2 Global Pharma and Health Care Market Size by Region, (2018-2029)
       1.6.3 North America Pharma and Health Care Market Size and Prospect (2018-2029)
       1.6.4 Europe Pharma and Health Care Market Size and Prospect (2018-2029)
       1.6.5 Asia-Pacific Pharma and Health Care Market Size and Prospect (2018-2029)
       1.6.6 South America Pharma and Health Care Market Size and Prospect (2018-2029)
       1.6.7 Middle East and Africa Pharma and Health Care Market Size and Prospect (2018-2029)

2 Company Profiles

   2.1 Johnson & Johnson
       2.1.1 Johnson & Johnson Details
       2.1.2 Johnson & Johnson Major Business
       2.1.3 Johnson & Johnson Pharma and Health Care Product and Solutions
       2.1.4 Johnson & Johnson Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Johnson & Johnson Recent Developments and Future Plans
   2.2 Novartis
       2.2.1 Novartis Details
       2.2.2 Novartis Major Business
       2.2.3 Novartis Pharma and Health Care Product and Solutions
       2.2.4 Novartis Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Novartis Recent Developments and Future Plans
   2.3 Roche
       2.3.1 Roche Details
       2.3.2 Roche Major Business
       2.3.3 Roche Pharma and Health Care Product and Solutions
       2.3.4 Roche Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Roche Recent Developments and Future Plans
   2.4 AbbVie
       2.4.1 AbbVie Details
       2.4.2 AbbVie Major Business
       2.4.3 AbbVie Pharma and Health Care Product and Solutions
       2.4.4 AbbVie Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 AbbVie Recent Developments and Future Plans
   2.5 Merck & Co.
       2.5.1 Merck & Co. Details
       2.5.2 Merck & Co. Major Business
       2.5.3 Merck & Co. Pharma and Health Care Product and Solutions
       2.5.4 Merck & Co. Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Merck & Co. Recent Developments and Future Plans
   2.6 Bristol Myers Squibb
       2.6.1 Bristol Myers Squibb Details
       2.6.2 Bristol Myers Squibb Major Business
       2.6.3 Bristol Myers Squibb Pharma and Health Care Product and Solutions
       2.6.4 Bristol Myers Squibb Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Bristol Myers Squibb Recent Developments and Future Plans
   2.7 GlaxoSmithKline
       2.7.1 GlaxoSmithKline Details
       2.7.2 GlaxoSmithKline Major Business
       2.7.3 GlaxoSmithKline Pharma and Health Care Product and Solutions
       2.7.4 GlaxoSmithKline Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 GlaxoSmithKline Recent Developments and Future Plans
   2.8 Pfizer
       2.8.1 Pfizer Details
       2.8.2 Pfizer Major Business
       2.8.3 Pfizer Pharma and Health Care Product and Solutions
       2.8.4 Pfizer Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Pfizer Recent Developments and Future Plans
   2.9 Sanofi
       2.9.1 Sanofi Details
       2.9.2 Sanofi Major Business
       2.9.3 Sanofi Pharma and Health Care Product and Solutions
       2.9.4 Sanofi Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Sanofi Recent Developments and Future Plans
   2.10 Takeda 
       2.10.1 Takeda Details
       2.10.2 Takeda Major Business
       2.10.3 Takeda Pharma and Health Care Product and Solutions
       2.10.4 Takeda Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 Takeda Recent Developments and Future Plans
   2.11 AstraZeneca
       2.11.1 AstraZeneca Details
       2.11.2 AstraZeneca Major Business
       2.11.3 AstraZeneca Pharma and Health Care Product and Solutions
       2.11.4 AstraZeneca Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 AstraZeneca Recent Developments and Future Plans
   2.12 Bayer
       2.12.1 Bayer Details
       2.12.2 Bayer Major Business
       2.12.3 Bayer Pharma and Health Care Product and Solutions
       2.12.4 Bayer Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 Bayer Recent Developments and Future Plans
   2.13 Eli Lilly & Co.
       2.13.1 Eli Lilly & Co. Details
       2.13.2 Eli Lilly & Co. Major Business
       2.13.3 Eli Lilly & Co. Pharma and Health Care Product and Solutions
       2.13.4 Eli Lilly & Co. Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.13.5 Eli Lilly & Co. Recent Developments and Future Plans
   2.14 Gilead Sciences
       2.14.1 Gilead Sciences Details
       2.14.2 Gilead Sciences Major Business
       2.14.3 Gilead Sciences Pharma and Health Care Product and Solutions
       2.14.4 Gilead Sciences Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.14.5 Gilead Sciences Recent Developments and Future Plans
   2.15 Amgen
       2.15.1 Amgen Details
       2.15.2 Amgen Major Business
       2.15.3 Amgen Pharma and Health Care Product and Solutions
       2.15.4 Amgen Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.15.5 Amgen Recent Developments and Future Plans
   2.16 Novo Nordisk
       2.16.1 Novo Nordisk Details
       2.16.2 Novo Nordisk Major Business
       2.16.3 Novo Nordisk Pharma and Health Care Product and Solutions
       2.16.4 Novo Nordisk Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.16.5 Novo Nordisk Recent Developments and Future Plans
   2.17 Teva
       2.17.1 Teva Details
       2.17.2 Teva Major Business
       2.17.3 Teva Pharma and Health Care Product and Solutions
       2.17.4 Teva Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.17.5 Teva Recent Developments and Future Plans
   2.18 Boehringer Ingelheim
       2.18.1 Boehringer Ingelheim Details
       2.18.2 Boehringer Ingelheim Major Business
       2.18.3 Boehringer Ingelheim Pharma and Health Care Product and Solutions
       2.18.4 Boehringer Ingelheim Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.18.5 Boehringer Ingelheim Recent Developments and Future Plans
   2.19 Biogen
       2.19.1 Biogen Details
       2.19.2 Biogen Major Business
       2.19.3 Biogen Pharma and Health Care Product and Solutions
       2.19.4 Biogen Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.19.5 Biogen Recent Developments and Future Plans
   2.20 Astellas
       2.20.1 Astellas Details
       2.20.2 Astellas Major Business
       2.20.3 Astellas Pharma and Health Care Product and Solutions
       2.20.4 Astellas Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
       2.20.5 Astellas Recent Developments and Future Plans

3 Market Competition, by Players

   3.1 Global Pharma and Health Care Revenue and Share by Players (2018-2023)
   3.2 Market Share Analysis (2022)
       3.2.1 Market Share of Pharma and Health Care by Company Revenue
       3.2.2 Top 3 Pharma and Health Care Players Market Share in 2022
       3.2.3 Top 6 Pharma and Health Care Players Market Share in 2022
   3.3 Pharma and Health Care Market: Overall Company Footprint Analysis
       3.3.1 Pharma and Health Care Market: Region Footprint
       3.3.2 Pharma and Health Care Market: Company Product Type Footprint
       3.3.3 Pharma and Health Care Market: Company Product Application Footprint
   3.4 New Market Entrants and Barriers to Market Entry
   3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Format

   4.1 Global Pharma and Health Care Consumption Value and Market Share by Format (2018-2023)
   4.2 Global Pharma and Health Care Market Forecast by Format (2024-2029)

5 Market Size Segment by Prescription

   5.1 Global Pharma and Health Care Consumption Value Market Share by Prescription (2018-2023)
   5.2 Global Pharma and Health Care Market Forecast by Prescription (2024-2029)

6 North America

   6.1 North America Pharma and Health Care Consumption Value by Format (2018-2029)
   6.2 North America Pharma and Health Care Consumption Value by Prescription (2018-2029)
   6.3 North America Pharma and Health Care Market Size by Country
       6.3.1 North America Pharma and Health Care Consumption Value by Country (2018-2029)
       6.3.2 United States Pharma and Health Care Market Size and Forecast (2018-2029)
       6.3.3 Canada Pharma and Health Care Market Size and Forecast (2018-2029)
       6.3.4 Mexico Pharma and Health Care Market Size and Forecast (2018-2029)

7 Europe

   7.1 Europe Pharma and Health Care Consumption Value by Format (2018-2029)
   7.2 Europe Pharma and Health Care Consumption Value by Prescription (2018-2029)
   7.3 Europe Pharma and Health Care Market Size by Country
       7.3.1 Europe Pharma and Health Care Consumption Value by Country (2018-2029)
       7.3.2 Germany Pharma and Health Care Market Size and Forecast (2018-2029)
       7.3.3 France Pharma and Health Care Market Size and Forecast (2018-2029)
       7.3.4 United Kingdom Pharma and Health Care Market Size and Forecast (2018-2029)
       7.3.5 Russia Pharma and Health Care Market Size and Forecast (2018-2029)
       7.3.6 Italy Pharma and Health Care Market Size and Forecast (2018-2029)

8 Asia-Pacific

   8.1 Asia-Pacific Pharma and Health Care Consumption Value by Format (2018-2029)
   8.2 Asia-Pacific Pharma and Health Care Consumption Value by Prescription (2018-2029)
   8.3 Asia-Pacific Pharma and Health Care Market Size by Region
       8.3.1 Asia-Pacific Pharma and Health Care Consumption Value by Region (2018-2029)
       8.3.2 China Pharma and Health Care Market Size and Forecast (2018-2029)
       8.3.3 Japan Pharma and Health Care Market Size and Forecast (2018-2029)
       8.3.4 South Korea Pharma and Health Care Market Size and Forecast (2018-2029)
       8.3.5 India Pharma and Health Care Market Size and Forecast (2018-2029)
       8.3.6 Southeast Asia Pharma and Health Care Market Size and Forecast (2018-2029)
       8.3.7 Australia Pharma and Health Care Market Size and Forecast (2018-2029)

9 South America

   9.1 South America Pharma and Health Care Consumption Value by Format (2018-2029)
   9.2 South America Pharma and Health Care Consumption Value by Prescription (2018-2029)
   9.3 South America Pharma and Health Care Market Size by Country
       9.3.1 South America Pharma and Health Care Consumption Value by Country (2018-2029)
       9.3.2 Brazil Pharma and Health Care Market Size and Forecast (2018-2029)
       9.3.3 Argentina Pharma and Health Care Market Size and Forecast (2018-2029)

10 Middle East & Africa

   10.1 Middle East & Africa Pharma and Health Care Consumption Value by Format (2018-2029)
   10.2 Middle East & Africa Pharma and Health Care Consumption Value by Prescription (2018-2029)
   10.3 Middle East & Africa Pharma and Health Care Market Size by Country
       10.3.1 Middle East & Africa Pharma and Health Care Consumption Value by Country (2018-2029)
       10.3.2 Turkey Pharma and Health Care Market Size and Forecast (2018-2029)
       10.3.3 Saudi Arabia Pharma and Health Care Market Size and Forecast (2018-2029)
       10.3.4 UAE Pharma and Health Care Market Size and Forecast (2018-2029)

11 Market Dynamics

   11.1 Pharma and Health Care Market Drivers
   11.2 Pharma and Health Care Market Restraints
   11.3 Pharma and Health Care Trends Analysis
   11.4 Porters Five Forces Analysis
       11.4.1 Threat of New Entrants
       11.4.2 Bargaining Power of Suppliers
       11.4.3 Bargaining Power of Buyers
       11.4.4 Threat of Substitutes
       11.4.5 Competitive Rivalry
   11.5 Influence of COVID-19 and Russia-Ukraine War
       11.5.1 Influence of COVID-19
       11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

   12.1 Pharma and Health Care Industry Chain
   12.2 Pharma and Health Care Upstream Analysis
   12.3 Pharma and Health Care Midstream Analysis
   12.4 Pharma and Health Care Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

   14.1 Methodology
   14.2 Research Process and Data Source
   14.3 Disclaimer

List of Tables

   Table 1. Global Pharma and Health Care Consumption Value by Format, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Pharma and Health Care Consumption Value by Prescription, (USD Million), 2018 & 2022 & 2029
   Table 3. Global Pharma and Health Care Consumption Value by Region (2018-2023) & (USD Million)
   Table 4. Global Pharma and Health Care Consumption Value by Region (2024-2029) & (USD Million)
   Table 5. Johnson & Johnson Company Information, Head Office, and Major Competitors
   Table 6. Johnson & Johnson Major Business
   Table 7. Johnson & Johnson Pharma and Health Care Product and Solutions
   Table 8. Johnson & Johnson Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 9. Johnson & Johnson Recent Developments and Future Plans
   Table 10. Novartis Company Information, Head Office, and Major Competitors
   Table 11. Novartis Major Business
   Table 12. Novartis Pharma and Health Care Product and Solutions
   Table 13. Novartis Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 14. Novartis Recent Developments and Future Plans
   Table 15. Roche Company Information, Head Office, and Major Competitors
   Table 16. Roche Major Business
   Table 17. Roche Pharma and Health Care Product and Solutions
   Table 18. Roche Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 19. Roche Recent Developments and Future Plans
   Table 20. AbbVie Company Information, Head Office, and Major Competitors
   Table 21. AbbVie Major Business
   Table 22. AbbVie Pharma and Health Care Product and Solutions
   Table 23. AbbVie Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 24. AbbVie Recent Developments and Future Plans
   Table 25. Merck & Co. Company Information, Head Office, and Major Competitors
   Table 26. Merck & Co. Major Business
   Table 27. Merck & Co. Pharma and Health Care Product and Solutions
   Table 28. Merck & Co. Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 29. Merck & Co. Recent Developments and Future Plans
   Table 30. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
   Table 31. Bristol Myers Squibb Major Business
   Table 32. Bristol Myers Squibb Pharma and Health Care Product and Solutions
   Table 33. Bristol Myers Squibb Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 34. Bristol Myers Squibb Recent Developments and Future Plans
   Table 35. GlaxoSmithKline Company Information, Head Office, and Major Competitors
   Table 36. GlaxoSmithKline Major Business
   Table 37. GlaxoSmithKline Pharma and Health Care Product and Solutions
   Table 38. GlaxoSmithKline Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 39. GlaxoSmithKline Recent Developments and Future Plans
   Table 40. Pfizer Company Information, Head Office, and Major Competitors
   Table 41. Pfizer Major Business
   Table 42. Pfizer Pharma and Health Care Product and Solutions
   Table 43. Pfizer Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 44. Pfizer Recent Developments and Future Plans
   Table 45. Sanofi Company Information, Head Office, and Major Competitors
   Table 46. Sanofi Major Business
   Table 47. Sanofi Pharma and Health Care Product and Solutions
   Table 48. Sanofi Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 49. Sanofi Recent Developments and Future Plans
   Table 50. Takeda Company Information, Head Office, and Major Competitors
   Table 51. Takeda Major Business
   Table 52. Takeda Pharma and Health Care Product and Solutions
   Table 53. Takeda Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 54. Takeda Recent Developments and Future Plans
   Table 55. AstraZeneca Company Information, Head Office, and Major Competitors
   Table 56. AstraZeneca Major Business
   Table 57. AstraZeneca Pharma and Health Care Product and Solutions
   Table 58. AstraZeneca Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 59. AstraZeneca Recent Developments and Future Plans
   Table 60. Bayer Company Information, Head Office, and Major Competitors
   Table 61. Bayer Major Business
   Table 62. Bayer Pharma and Health Care Product and Solutions
   Table 63. Bayer Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 64. Bayer Recent Developments and Future Plans
   Table 65. Eli Lilly & Co. Company Information, Head Office, and Major Competitors
   Table 66. Eli Lilly & Co. Major Business
   Table 67. Eli Lilly & Co. Pharma and Health Care Product and Solutions
   Table 68. Eli Lilly & Co. Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 69. Eli Lilly & Co. Recent Developments and Future Plans
   Table 70. Gilead Sciences Company Information, Head Office, and Major Competitors
   Table 71. Gilead Sciences Major Business
   Table 72. Gilead Sciences Pharma and Health Care Product and Solutions
   Table 73. Gilead Sciences Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 74. Gilead Sciences Recent Developments and Future Plans
   Table 75. Amgen Company Information, Head Office, and Major Competitors
   Table 76. Amgen Major Business
   Table 77. Amgen Pharma and Health Care Product and Solutions
   Table 78. Amgen Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 79. Amgen Recent Developments and Future Plans
   Table 80. Novo Nordisk Company Information, Head Office, and Major Competitors
   Table 81. Novo Nordisk Major Business
   Table 82. Novo Nordisk Pharma and Health Care Product and Solutions
   Table 83. Novo Nordisk Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 84. Novo Nordisk Recent Developments and Future Plans
   Table 85. Teva Company Information, Head Office, and Major Competitors
   Table 86. Teva Major Business
   Table 87. Teva Pharma and Health Care Product and Solutions
   Table 88. Teva Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 89. Teva Recent Developments and Future Plans
   Table 90. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
   Table 91. Boehringer Ingelheim Major Business
   Table 92. Boehringer Ingelheim Pharma and Health Care Product and Solutions
   Table 93. Boehringer Ingelheim Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 94. Boehringer Ingelheim Recent Developments and Future Plans
   Table 95. Biogen Company Information, Head Office, and Major Competitors
   Table 96. Biogen Major Business
   Table 97. Biogen Pharma and Health Care Product and Solutions
   Table 98. Biogen Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 99. Biogen Recent Developments and Future Plans
   Table 100. Astellas Company Information, Head Office, and Major Competitors
   Table 101. Astellas Major Business
   Table 102. Astellas Pharma and Health Care Product and Solutions
   Table 103. Astellas Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 104. Astellas Recent Developments and Future Plans
   Table 105. Global Pharma and Health Care Revenue (USD Million) by Players (2018-2023)
   Table 106. Global Pharma and Health Care Revenue Share by Players (2018-2023)
   Table 107. Breakdown of Pharma and Health Care by Company Type (Tier 1, Tier 2, and Tier 3)
   Table 108. Market Position of Players in Pharma and Health Care, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
   Table 109. Head Office of Key Pharma and Health Care Players
   Table 110. Pharma and Health Care Market: Company Product Type Footprint
   Table 111. Pharma and Health Care Market: Company Product Application Footprint
   Table 112. Pharma and Health Care New Market Entrants and Barriers to Market Entry
   Table 113. Pharma and Health Care Mergers, Acquisition, Agreements, and Collaborations
   Table 114. Global Pharma and Health Care Consumption Value (USD Million) by Format (2018-2023)
   Table 115. Global Pharma and Health Care Consumption Value Share by Format (2018-2023)
   Table 116. Global Pharma and Health Care Consumption Value Forecast by Format (2024-2029)
   Table 117. Global Pharma and Health Care Consumption Value by Prescription (2018-2023)
   Table 118. Global Pharma and Health Care Consumption Value Forecast by Prescription (2024-2029)
   Table 119. North America Pharma and Health Care Consumption Value by Format (2018-2023) & (USD Million)
   Table 120. North America Pharma and Health Care Consumption Value by Format (2024-2029) & (USD Million)
   Table 121. North America Pharma and Health Care Consumption Value by Prescription (2018-2023) & (USD Million)
   Table 122. North America Pharma and Health Care Consumption Value by Prescription (2024-2029) & (USD Million)
   Table 123. North America Pharma and Health Care Consumption Value by Country (2018-2023) & (USD Million)
   Table 124. North America Pharma and Health Care Consumption Value by Country (2024-2029) & (USD Million)
   Table 125. Europe Pharma and Health Care Consumption Value by Format (2018-2023) & (USD Million)
   Table 126. Europe Pharma and Health Care Consumption Value by Format (2024-2029) & (USD Million)
   Table 127. Europe Pharma and Health Care Consumption Value by Prescription (2018-2023) & (USD Million)
   Table 128. Europe Pharma and Health Care Consumption Value by Prescription (2024-2029) & (USD Million)
   Table 129. Europe Pharma and Health Care Consumption Value by Country (2018-2023) & (USD Million)
   Table 130. Europe Pharma and Health Care Consumption Value by Country (2024-2029) & (USD Million)
   Table 131. Asia-Pacific Pharma and Health Care Consumption Value by Format (2018-2023) & (USD Million)
   Table 132. Asia-Pacific Pharma and Health Care Consumption Value by Format (2024-2029) & (USD Million)
   Table 133. Asia-Pacific Pharma and Health Care Consumption Value by Prescription (2018-2023) & (USD Million)
   Table 134. Asia-Pacific Pharma and Health Care Consumption Value by Prescription (2024-2029) & (USD Million)
   Table 135. Asia-Pacific Pharma and Health Care Consumption Value by Region (2018-2023) & (USD Million)
   Table 136. Asia-Pacific Pharma and Health Care Consumption Value by Region (2024-2029) & (USD Million)
   Table 137. South America Pharma and Health Care Consumption Value by Format (2018-2023) & (USD Million)
   Table 138. South America Pharma and Health Care Consumption Value by Format (2024-2029) & (USD Million)
   Table 139. South America Pharma and Health Care Consumption Value by Prescription (2018-2023) & (USD Million)
   Table 140. South America Pharma and Health Care Consumption Value by Prescription (2024-2029) & (USD Million)
   Table 141. South America Pharma and Health Care Consumption Value by Country (2018-2023) & (USD Million)
   Table 142. South America Pharma and Health Care Consumption Value by Country (2024-2029) & (USD Million)
   Table 143. Middle East & Africa Pharma and Health Care Consumption Value by Format (2018-2023) & (USD Million)
   Table 144. Middle East & Africa Pharma and Health Care Consumption Value by Format (2024-2029) & (USD Million)
   Table 145. Middle East & Africa Pharma and Health Care Consumption Value by Prescription (2018-2023) & (USD Million)
   Table 146. Middle East & Africa Pharma and Health Care Consumption Value by Prescription (2024-2029) & (USD Million)
   Table 147. Middle East & Africa Pharma and Health Care Consumption Value by Country (2018-2023) & (USD Million)
   Table 148. Middle East & Africa Pharma and Health Care Consumption Value by Country (2024-2029) & (USD Million)
   Table 149. Pharma and Health Care Raw Material
   Table 150. Key Suppliers of Pharma and Health Care Raw Materials

List of Figures

   Figure 1. Pharma and Health Care Picture
   Figure 2. Global Pharma and Health Care Consumption Value by Format, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Pharma and Health Care Consumption Value Market Share by Format in 2022
   Figure 4. Bottle
   Figure 5. Blister
   Figure 6. Others
   Figure 7. Global Pharma and Health Care Consumption Value by Format, (USD Million), 2018 & 2022 & 2029
   Figure 8. Pharma and Health Care Consumption Value Market Share by Prescription in 2022
   Figure 9. OTC Drugs Picture
   Figure 10. Prescription Drugs Picture
   Figure 11. Global Pharma and Health Care Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 12. Global Pharma and Health Care Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 13. Global Market Pharma and Health Care Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
   Figure 14. Global Pharma and Health Care Consumption Value Market Share by Region (2018-2029)
   Figure 15. Global Pharma and Health Care Consumption Value Market Share by Region in 2022
   Figure 16. North America Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 17. Europe Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 18. Asia-Pacific Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 19. South America Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 20. Middle East and Africa Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 21. Global Pharma and Health Care Revenue Share by Players in 2022
   Figure 22. Pharma and Health Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
   Figure 23. Global Top 3 Players Pharma and Health Care Market Share in 2022
   Figure 24. Global Top 6 Players Pharma and Health Care Market Share in 2022
   Figure 25. Global Pharma and Health Care Consumption Value Share by Format (2018-2023)
   Figure 26. Global Pharma and Health Care Market Share Forecast by Format (2024-2029)
   Figure 27. Global Pharma and Health Care Consumption Value Share by Prescription (2018-2023)
   Figure 28. Global Pharma and Health Care Market Share Forecast by Prescription (2024-2029)
   Figure 29. North America Pharma and Health Care Consumption Value Market Share by Format (2018-2029)
   Figure 30. North America Pharma and Health Care Consumption Value Market Share by Prescription (2018-2029)
   Figure 31. North America Pharma and Health Care Consumption Value Market Share by Country (2018-2029)
   Figure 32. United States Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 33. Canada Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 34. Mexico Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 35. Europe Pharma and Health Care Consumption Value Market Share by Format (2018-2029)
   Figure 36. Europe Pharma and Health Care Consumption Value Market Share by Prescription (2018-2029)
   Figure 37. Europe Pharma and Health Care Consumption Value Market Share by Country (2018-2029)
   Figure 38. Germany Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 39. France Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 40. United Kingdom Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 41. Russia Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 42. Italy Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 43. Asia-Pacific Pharma and Health Care Consumption Value Market Share by Format (2018-2029)
   Figure 44. Asia-Pacific Pharma and Health Care Consumption Value Market Share by Prescription (2018-2029)
   Figure 45. Asia-Pacific Pharma and Health Care Consumption Value Market Share by Region (2018-2029)
   Figure 46. China Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 47. Japan Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 48. South Korea Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 49. India Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 50. Southeast Asia Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 51. Australia Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 52. South America Pharma and Health Care Consumption Value Market Share by Format (2018-2029)
   Figure 53. South America Pharma and Health Care Consumption Value Market Share by Prescription (2018-2029)
   Figure 54. South America Pharma and Health Care Consumption Value Market Share by Country (2018-2029)
   Figure 55. Brazil Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 56. Argentina Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 57. Middle East and Africa Pharma and Health Care Consumption Value Market Share by Format (2018-2029)
   Figure 58. Middle East and Africa Pharma and Health Care Consumption Value Market Share by Prescription (2018-2029)
   Figure 59. Middle East and Africa Pharma and Health Care Consumption Value Market Share by Country (2018-2029)
   Figure 60. Turkey Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 61. Saudi Arabia Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 62. UAE Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
   Figure 63. Pharma and Health Care Market Drivers
   Figure 64. Pharma and Health Care Market Restraints
   Figure 65. Pharma and Health Care Market Trends
   Figure 66. Porters Five Forces Analysis
   Figure 67. Manufacturing Cost Structure Analysis of Pharma and Health Care in 2022
   Figure 68. Manufacturing Process Analysis of Pharma and Health Care
   Figure 69. Pharma and Health Care Industrial Chain
   Figure 70. Methodology
   Figure 71. Research Process and Data Source